ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,615Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 52

$1.01M Total Retail Price of All Prescriptions

Rank: 1 out of 52

505 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 505 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

20% of this provider’s 505 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,895 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 751 656 1 7
HYDROCODONE-ACETAMINOPHEN 546 309 S3 2 3
SIMVASTATIN 517 465 3 1
OMEPRAZOLE 483 415 4 6
LISINOPRIL 454 374 5 2
LEVOTHYROXINE SODIUM 439 379 6 5
TRAMADOL HCL 388 327 7 14
WARFARIN SODIUM 375 372 8 13
METOPROLOL TARTRATE 374 349 9 11
CITALOPRAM HBR 334 264 10 28
GABAPENTIN 298 181 11 10
DONEPEZIL HCL 278 267 12 26
AMLODIPINE BESYLATE 270 222 13 4
ATENOLOL 261 201 14 17
METFORMIN HCL 231 190 15 8
POTASSIUM CHLORIDE 217 206 16 18
NAMENDA 208 206 17 46
QUETIAPINE FUMARATE 206 191 18 49
TRAZODONE HCL 200 105 19 29
CARVEDILOL 199 184 20 31
KLOR-CON M20 197 164 21 40
POLYETHYLENE GLYCOL 3350 186 166 22 41
LANTUS 178 166 23 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 164 139 24 16
ZOLPIDEM TARTRATE 156 104 25 20
AMOXICILLIN 152 95 26 56
ATORVASTATIN CALCIUM 150 129 27 12
MELOXICAM 147 102 28 33
PRAVASTATIN SODIUM 143 109 29 19
HYDROCHLOROTHIAZIDE 142 123 30 9
NEXIUM 138 78 31 27
FAMOTIDINE 137 122 32 73
AZITHROMYCIN 134 115 33 34
CYMBALTA 133 74 34 39
SERTRALINE HCL 133 103 34 24
PROMETHAZINE HCL 127 69 R 36 75
PANTOPRAZOLE SODIUM 127 103 36 45
TAMSULOSIN HCL 122 97 38 35
MIRTAZAPINE 115 99 39 80
LOSARTAN POTASSIUM 114 111 40 25
GLIMEPIRIDE 114 108 40 38
ALENDRONATE SODIUM 106 105 42 42
SPIRIVA 103 79 43 78
CLOPIDOGREL 102 94 44 36
IPRATROPIUM-ALBUTEROL 101 101 45 132
RISPERIDONE 98 84 46 70
PREDNISONE 97 76 47 64
ESCITALOPRAM OXALATE 96 87 48 59
HYDROXYZINE HCL 92 82 R 49 99
ADVAIR DISKUS 92 53 49 52
PLAVIX 88 79 51 47
CIPROFLOXACIN HCL 85 68 52 69
FLUOXETINE HCL 82 53 53 64
KLOR-CON M10 79 72 54 106
RANITIDINE HCL 78 66 55 23
FENOFIBRATE 75 54 56 114
CRESTOR 75 48 56 30
ISOSORBIDE MONONITRATE ER 73 63 58 74
TRIAMCINOLONE ACETONIDE 72 62 59 112
LACTULOSE 72 63 59 144
CEPHALEXIN 72 64 59 77
SEROQUEL 71 67 62 102
METOPROLOL SUCCINATE 71 70 62 15
CYCLOBENZAPRINE HCL 69 34 R 64 58
PAROXETINE HCL 68 54 65 72
PHENYTOIN SODIUM EXTENDED 64 18 66 148
NOVOLOG 63 53 67 79
ALBUTEROL SULFATE 61 61 68 97
GLIPIZIDE 61 50 68 37
FENTANYL 59 49 S2 70 57
HUMALOG 59 32 70 155
SINGULAIR 59 29 70 122
BUSPIRONE HCL 59 43 70 95
NYSTATIN 59 49 70 155
NITROFURANTOIN MONO-MACRO 58 43 75 125
LATANOPROST 57 57 76 159
SPIRONOLACTONE 56 55 77 63
HYDRALAZINE HCL 56 39 77 86
GLUCAGEN 55 55 79 161
ALLOPURINOL 54 52 80 32
NORTRIPTYLINE HCL 52 23 81 166
MUPIROCIN 51 41 82 170
MONTELUKAST SODIUM 51 28 82 170
CARBIDOPA-LEVODOPA 50 39 84 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.